top
Search terms
Results 1 - 10 of 38 - ordered by :
Pages: 1 2 3 4
Ehjcardiovascrec

[...]this new knowledge has led to novel therapeutic possibilities to intervene against cardiovascular disease by targeting signalling in the RBC. In recent years, evidence have emerged suggesting ...

Cardiovascular Research, Pernow, John, Mahdi, Ali, Yang, Jiangning, Zhou, Zhichao

Date : 01/09/2019 Item size : 4416 bytes
Ehjcardiovascrec

According to the Global Burden of Disease study, cardiovascular risk factors and diseases such as hypertension, ischaemic heart disease, smoking, and cerebrovascular disease are the leading triggers ...

Cardiovascular Research, Münzel, Thomas, Daiber, Andreas

Date : 01/08/2018 Item size : 206245 bytes
Ehjournal

Methods and results Mortality, renal function, serum SDMA and HDL-cholesterol (HDL-C) were assessed in the LURIC study including 3310 subjects undergoing coronary angiography. Introduction ...

European Heart Journal, Zewinger, Stephen, Kleber, Marcus E., Rohrer, Lucia, Lehmann, Marlene, Triem, Sarah, Jennings, Richard T., Petrakis, Ioannis, Dressel, Alexander, Lepper, Philipp M., ...

Date : 21/05/2017 Item size : 426770 bytes
Ehjcardiovascrec

Increased activity of arginase may reduce the availability of l-arginine for NO synthase, thus reducing NO production, increasing formation of reactive oxygen species, and leading ultimately to ...

Cardiovascular Research, TOPICAL REVIEW, John Pernow, Christian Jung

Date : 01/06/2013
Ehjcardiovascrec

Most importantly, the demonstration was based on human data from a study in patients with peripheral vascular disease.3 The authors' reasoning was grounded on previous knowledge of the metabolism of ...

Cardiovascular Research, EDITORIALS: SPOTLIGHT ON LANDMARK PAPERS IN, Jean-Luc Balligand

Date : 01/11/2012
Ehjcardiovascrec

1.1 Hyperhomocysteinaemia In 1997, when we were designing our clinical study, hyperhomocysteinaemia was considered to be a potential independent cardiovascular risk factor.1,2 A variety of underlying ...

Cardiovascular Research, EDITORIALS: SPOTLIGHT ON LANDMARK PAPERS IN, Karsten Sydow, Rainer H. Böger

Date : 01/11/2012
Ehjcardiovascrec

Hyperhomocysteinaemia In 1997, when we were designing our clinical study, hyperhomocysteinaemia was considered to be a potential independent cardiovascular risk factor.1,2 A variety of underlying ...

Cardiovascular Research, Sydow, Karsten, Böger, Rainer H.

Date : 01/11/2012
Ehjcardiovascrec

Solid epidemiological data have established the increased risk of cardiovascular disease with elevated plasma homocysteine levels.1,2 Yet, interventional studies with proven efficacy to reduce ...

Cardiovascular Research, Balligand, Jean-Luc

Date : 01/11/2012 Item size : 147899 bytes
Ehjcardiovascrec

1.1 Hyperhomocysteinaemia In 1997, when we were designing our clinical study, hyperhomocysteinaemia was considered to be a potential independent cardiovascular risk factor.1,2 A variety of underlying ...

Cardiovascular Research, Sydow, Karsten, Böger, Rainer H.

Date : 01/11/2012 Item size : 214124 bytes
Ehjcardiovascrec

In addition to their lipid-lowering effects, one central biological action of statins is their ability to ameliorate the impaired bioavailability of NO.1 Mechanistically, this occurs through ...

Cardiovascular Research, Editorial, Stephan H. Schirmer, Christian M. Werner, Ulrich Laufs, Michael Böhm

Date : 01/06/2012 Item size : 181712 bytes